Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipyrine-benzocaine otic solution in moderate to severe asthma
NCT02153541Phase 2Unknown
- Sponsor
- Global United Pharmaceutical Corporation
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antipyrine, benzocaine in asthma, sponsored by Global United Pharmaceutical Corporation. Status: unknown.
02
Drugs
antipyrinebenzocaine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02153541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02153541.